Allergy and Infectious Diseases Research in Delaware
Allergy and Infectious Diseases Research (93.855) awarded $7.4 million to recipients in Delaware in 13 grants from fiscal 2021 to 2025, less than 0.1% of the program's national total. University of Delaware received the most, $3.3 million.
- Awarded in Delaware$7.4 million
- Awards13
- Share of the programless than 0.1%
- Rank among states47th of 52
- National total$22 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 3 | $1.4 million |
| FY 2022 | 2 | $1.2 million |
| FY 2023 | 4 | $1.3 million |
| FY 2024 | 4 | $1.5 million |
| FY 2025 | 5 | $2.0 million |
Recipients in Delaware
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of Delaware | Colleges and universities | 5 | $3.3 million |
| Glycomira LLC | Small businesses | 2 | $2.6 million |
| Cellergy Pharma Inc. | Small businesses | 2 | $600,000 |
| Vishenary, LLC | Small businesses | 1 | $308,669 |
| Rna Therapeutics Inc. | Small businesses | 1 | $299,967 |
| The Nemours Foundation | Nonprofits | 1 | $177,500 |
| MSTM LLC | Small businesses | 1 | $159,060 |
Open opportunities under this program
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- Immune Tolerance Network (UM1 Clinical Trial Required)
- Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
- NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)
- Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
See all 93 on the program page
Questions people ask
How much Allergy and Infectious Diseases Research money goes to Delaware?
$7.4 million from fiscal 2021 to 2025, across 13 awards. Delaware ranks 47th of 52 states and territories for this program.
Who receives Allergy and Infectious Diseases Research money in Delaware?
The largest recipient is University of Delaware, with $3.3 million in 5 awards. Next are Glycomira LLC and Cellergy Pharma Inc..
Can organizations in Delaware apply now?
Yes, 93 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Allergy and Infectious Diseases Research in other states
Other large programs in Delaware
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Clean Energy Demonstrations
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Title I Grants to Local Educational Agencies
- Drinking Water State Revolving Fund
- 1332 State Innovation Waivers
- Special Education Grants to States